When the Hospital Is Hundreds of Miles Away: The Complexities of Medical Transport 

Posted on by Joseph Gerard

Speeding ambulanceWritten by Marchelle Abrahams,

The search for a missing air ambulance drew widespread news coverage over the weekend. A medical crew was reportedly transporting a patient and a family member from Bermuda to Boston when the plane went missing off the coast of Nantucket Island.

The unfortunate incident has left many questions unanswered, including how an aircraft could disappear moments after losing contact with air traffic control. 

And the 800-pound gorilla that hospital case managers are wondering about: transporting patients is a complicated web of safety and protocol. Where were the weak spots?

Answers remain vague, but that doesn’t discount the fact that medical transportation is a complex system that becomes even more intricate when the hospital is states away.

 

The Growing Need for Medical Transport

An aging population, rising rates of chronic illness, and a push to reduce missed medical appointments are part of the demand.

They’re also why the U.S. non-emergency medical transportation (NEMT) market is expected to grow to $13.43 billion by 2031, according to Research and Markets data.

NEMT providers serve Medicaid beneficiaries and patients in need of transportation to medical facilities for regular appointments and check-ups. Ambulance services, wheelchair assistance, stretcher services, flight services, and courier services are included.

However, working in healthcare gives us a bird’s-eye view of the challenges. Hospital case managers are probably the ones to witness this firsthand.

Inflation and operating costs leave many providers feeling squeezed, particularly in rural regions. The industry continues to face hurdles related to administrative complexity, broker dependencies, and compliance.

But we’re seeing some improvement. Strategy & Stats reports that collaborations among hospitals, private air medical transport companies, and insurers are improving coordination of patient transfer services and increasing access to air transportation services.

 

When Specialist Care Crosses State Lines 

Interstate medical transportation isn’t as cut-and-dry as transporting a patient and being done with it. Well, that’s what the general public thinks.

When it comes to medical transportation between states, providers must navigate a patchwork of federal rules, insurance policies, and operational scopes. There’s no single universal long-distance law dealing with interstate patient transport.

Hospital case managers and discharge planners usually handle the logistics of long-distance hospital transport. Discharge planning alone requires mountains of admin work. ACC Medlink suggests enlisting a professional, reliable transport partner that can provide documentation support.

 

The Role of Case Managers in Patient Transfers 

Nurse case managers are the unsung busy bees working behind the scenes. You ensure a patient’s transfer is safe, smooth, and continuous across care settings.

You evaluate the patient’s physical status, monitor vital signs, and decide whether the patient is stable enough for movement.

Probably your most underestimated role is advocating for your patient. You explain the inner workings of transferring them from one hospital to another facility and provide a vital link between them and their care team.

“During the 1960s and in subsequent decades, a growing patient rights movement embraced the importance of informed consent for honoring patients’ autonomy. Patient advocates arose as an important voice in this movement by educating patients about their rights and helping them participate more fully in decisions about their healthcare.” – Jennifer Schlinger, Clinical Associate Professor of Social Work, via The Conversation.

 

Access Barriers

Delayed care will remain a moot point as long as access to medical transport is only reserved for those who can afford it.

A 2024 review published in the Journal of Transport & Health paints a multifaceted picture. People in rural communities have to travel long distances to access healthcare services. The link between distance and/or travel time and healthcare service access hasn’t always been clear. 

The research looked at how distance and travel time affect access to healthcare for people living in rural and remote areas of developed countries. It found that travel time may be a better measure of healthcare access than distance, particularly for people living outside major cities.

 

FAQs

What is medical transportation between states?

Medical transportation between states refers to moving a patient across state lines to access healthcare. Depending on the patient’s condition, this can involve ground ambulances, non-emergency medical transportation, wheelchair or stretcher services, or medical flights.

Who arranges interstate medical transportation?

Hospital case managers, discharge planners, and healthcare teams often coordinate patient transfers. They may need to assess the patient’s medical needs, communicate with the receiving facility, arrange transportation, and ensure the necessary documentation is in place.

Why might a patient need to travel to another state for medical care?

Patients may need to cross state lines when specialized treatment is unavailable locally. This can include specialist consultations, advanced procedures, rehabilitation, transplant services, or treatment at a facility with specific expertise.

Is medical transportation between states covered by insurance?

Interstate medical transportation coverage depends on the patient’s insurance plan, medical needs, and the type of transportation required. Medicaid and private insurers may have specific eligibility and authorization requirements, so patients and care teams should confirm coverage before arranging transportation.

 

Medical Transportation: Key Stats 

Stat What it Tells Us
$13.43 billion Projected value of the U.S. non-emergency medical transportation market by 2031 
Travel time vs. distance Research suggests travel time may provide a better picture of healthcare access than distance alone
Cross-state transfers Interstate transfers can involve coordination between hospitals, insurers, transport providers, and healthcare professionals
Multiple transport options NEMT can include ambulances, wheelchair transport, stretcher services, medical flights, and courier services

 

Getting Patients There Is Part of the Care 

Healthcare doesn’t end when a patient leaves one hospital. Transporting them to the next facility is just as important. We may not know what happened on that fateful air ambulance flight.

But we do know it doesn’t define the NEMT industry. Yes, challenges remain top of mind, yet every case manager’s goal is to get patients from point A to point B with as few complications as possible.

Author bio

Writer by day, dream catcher by night. Marchelle Abrahams cut her teeth in the infancy of the internet when the dial-up sound of the modem was more than a soundbite at a rave. Not a Millennial and not a Boomer, Marchelle is an in-betweener, making her a special breed of human. As a qualified journalist, Marchelle believes her superpower is stringing a few words together and people reading them.

 

References:

Search suspended for missing Ontario-based air ambulance with four Canadians aboard : U.S. Coast Guard. (2026, October 5). Nationalpost. https://nationalpost.com/news/four-canadians-aboard-ontario-based-air-ambulance-missing-off-u-s-coast 

Ltd, R. a. M. (n.d.). US Non-Emergency Medical Transportation Market Size & Trends. Research and Markets Ltd 2026. https://www.researchandmarkets.com/report/united-states-non-emergency-medical-transportation-market 

Kardani, P. (2026, October 7). U.S. air ambulance services industry: emergency care insights. SNS Insider. https://www.snsinsider.com/blogs/air-ambulance-services-industry 

Schlinger, J. (n.d.). What is a professional patient advocate, and why might you need one? The Conversation. https://theconversation.com/what-is-a-professional-patient-advocate-and-why-might-you-need-one-281971 

Impact of distance and/or travel time on healthcare service access in rural and remote areas: A scoping review. Journal of Transport & Health July 2024. https://www.sciencedirect.com/science/article/pii/S2214140524000653 

Us, J. K. W. (2026, October 5). A surgeon shortage creates challenges in rural communities. The Week US. https://theweek.com/health/a-surgeon-shortage-creates-challenges-in-rural-communities 

Please also review AIHCP’s Case Management Certification program and our CE courses as well, to see if they meet your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Reduction, Not Only Abstinence: Meeting Patients in the “Gray Area” of Alcohol Use

Posted on by Joseph Gerard

drunk man drinking alcohol at table at night. Acceptable or in the gray area of alcohol use?

Most people whose drinking exceeds healthy limits will never walk into an addiction clinic. They are not dependent on alcohol, and they do not meet the criteria for a severe use disorder. Many are not looking for treatment at all. Their drinking is still not harmless, and a growing number of them know it. They sit in what clinicians and patients alike describe as a gray area: too much to ignore, not enough to resemble the treatment system as most people picture it.

The clinical term of art for this group is “unhealthy alcohol use.” The U.S. Preventive Services Task Force (USPSTF) defines it as a spectrum of behaviors that runs from risky drinking to alcohol use disorder. Risky or hazardous drinking means drinking above recommended limits, in a pattern that raises the risk of health consequences without meeting the criteria for an alcohol use disorder. An alcohol use disorder is a different matter: a medical condition in which a person struggles to stop or control drinking despite the consequences, and it can be mild, moderate, or severe.

The distinction shapes how care is organized. A person who drinks above the limits but has no disorder is unlikely to accept, or need, an abstinence-only pathway. A person with a severe disorder needs much more than a brief conversation. Between those poles lies a large, quiet group that the health system mostly misses.

Why this group is easy to miss

People who drink in the gray area rarely describe themselves as having a problem. Popular culture still draws a hard line between “alcoholics” and everyone else, and that framing can work against early change: when cutting back reads as an admission of a problem, reluctance to try tends to grow. Research documents a second barrier. A scoping review led by clinical psychologist Devin Banks found that Black people in substance use treatment feared being judged by employers, police, and others, and that this stigma can be a barrier to treatment.

Drinking to cope is also normalized. About two-thirds of adults in the United States report drinking in the past year, and nearly a quarter report binge drinking in the past month. When a drink is how someone marks the end of a workday, cutting back is less a medical decision than a social and personal one.

The scale of the harm justifies attention. Excessive alcohol use is one of the most common causes of premature death in the United States; the Task Force cites an estimated 88,000 alcohol-attributable deaths a year from 2006 to 2010, from acute causes such as injuries and from chronic conditions such as liver disease.

What the evidence supports

Screening for unhealthy alcohol use in primary care, followed by brief behavioral counseling for patients who screen positive, carries the Task Force’s Grade B recommendation for adults 18 and older, including pregnant women. The Task Force concluded with moderate certainty that the net benefit is moderate. For adolescents aged 12 to 17, the evidence remains insufficient to weigh benefits against harms.

The benefit is real but not dramatic, and the numbers are worth knowing. Pooled trial results behind the recommendation show that brief counseling reduced the odds that a patient would exceed recommended drinking limits by roughly 40 percent (odds ratio 0.60; 95% CI, 0.53 to 0.67), and lowered the odds of a heavy-use episode by about a third, with outcomes measured at 6 to 12 months. The Task Force also bounded the harms of screening and brief counseling as small to none.

Two details keep the picture honest. The interventions that worked varied in their components, administration, length, and number of interactions, and the Task Force could not identify which characteristics were clearly associated with better outcomes; the conversation matters more than any fixed script. Part of the case for reduction also rests on indirect evidence: epidemiologic studies link reductions in drinking with lower risks of illness and death, even though they cannot show that a brief conversation produced the change on its own.

External assessments point in the same direction. The World Health Organization (WHO) has concluded that no level of alcohol consumption is safe for health, that alcohol causes at least seven types of cancer, and that risks start from the first drop of any alcoholic drink; as one WHO official puts it, the less you drink, the safer it is. A reduction-focused conversation does not have to settle debates about safe levels. It only has to help someone move in the safer direction.

The service model that carries this into practice is SBIRT: screening, brief intervention, and referral to treatment. The Substance Abuse and Mental Health Services Administration (SAMHSA) describes SBIRT as a public health approach to delivering early intervention and treatment services in primary care centers, hospital emergency rooms, trauma centers, and other community settings: a quick screen assesses the severity of use, a brief intervention builds insight and motivation toward change, and a referral pathway connects people who need more to specialty care.

What this looks like in practice

Whatever your role, you are better positioned than you may think. Nurses notice patterns at intake. Case managers hear how the week actually went. Chaplains and counselors sit with the stress that drinking is often managing. None of these roles requires prescribing authority, and none requires a full clinical assessment to be useful.

Screening can be short. One- to three-item instruments such as the AUDIT-C and the single alcohol screening question have the best accuracy for detecting unhealthy alcohol use in adults, and the AUDIT-C takes a minute or two to administer.

When someone screens positive, the brief intervention is a conversation rather than a lecture. In SAMHSA’s description, it works by increasing a person’s insight and awareness about their substance use and their motivation toward change. Cutting back and stopping altogether are both defensible goals; the evidence behind reduction-focused care is what makes it reasonable to support someone who is not ready to quit. People can take smaller steps toward health even when they are not ready for permanent abstinence. For patients who want structured support between visits, patient-facing programs such as Sunnyside offer app-based tracking, coaching, and clinician-supervised options for those who want to reduce. Programs like this work alongside clinical care, not in place of it, and they are one option among many a patient can weigh.

Language does quiet work here. “Alcoholic” remains a stigmatizing term, and the sober curiosity framing works partly by setting the label aside: anyone can try cutting back, without having to define themselves as a problem drinker first. And when a cutback attempt fails, that failure is information: practitioners in this space treat it as a signal that a plan, a goal, or a support level needs adjusting, not as proof that the person cannot change.

When moderation is not the right goal

Reduction-focused care has a safety boundary, and it is not optional. Moderation is not an appropriate goal for someone with a physical dependence on alcohol. Withdrawal in that situation can be fatal, and patients who become nauseated, shaky, or otherwise unwell when they try to cut back need supervised medical withdrawal rather than a self-guided plan. Some of those patients might be better off seeking permanent abstinence, and others need formal treatment; the treatment navigator listed below exists for that handoff. The screening recommendation itself is written for people who are not already in evaluation or treatment for alcohol problems.

Pregnancy is its own case: alcohol use during pregnancy is one of the major preventable causes of birth defects and developmental disabilities, and brief counseling increased the likelihood that women remained abstinent from alcohol during pregnancy.

The takeaway for practice

The next step for any role in this work is a small one. Screen when you can, and let the screening become a conversation about goals rather than a verdict about drinking. Treat reduction as a legitimate goal for patients who are not ready for abstinence, and keep the safety boundary in view: withdrawal risk and pregnancy belong with clinicians, and a timely handoff is part of the care. That is the practice in its everyday form: a question, a conversation, a goal the patient chooses, and a clear line where clinical care takes over.

Resources to share with patients and clients

Two free NIAAA resources are worth knowing by name. Rethinking Drinking offers practical tools for adults who want to examine or cut back on their drinking, including strategies for cutting down and a free booklet. The NIAAA Alcohol Treatment Navigator is aimed at people who may need treatment for an alcohol use disorder; it focuses on evidence-based care, includes questions to ask a potential provider, and carries no commercial sponsorship.

 

Author’s Bio:

This article is brought to you by the expert content team at nexuse backlinks agency, specializing in digital marketing, SEO, and quality online resources

 

Please also review AIHCP’s Substance Abuse Practitioner Program and  CE courses to see if it meets your academic and professional goals.

Where Patient Data Goes After the Handoff: The Hidden HIPAA Risk in Care Coordination

Posted on by Joseph Gerard

Medicine insurance security care for life. Hospital diagnosis design, health care document filling concept. Document health diagnoses medical insurance. Text and cartoon character vector illustration

Written by Ryan Harris,

A patient can leave the hospital with new prescriptions, follow-up visits, and home care already being arranged. Before they’ve even settled back in at home, parts of their medical record may have been sent to several different providers and systems.

That kind of movement is routine in healthcare. Care often depends on people in different offices and organizations being able to share information without slowing things down.

The trouble starts when everyone knows where the information came from, but nobody is quite sure where all the copies went. A discharge summary becomes an attachment. The attachment gets downloaded. Someone uploads it into another portal. A case manager keeps a working copy because the referral isn’t finished yet. None of those actions looks especially risky on its own.

Put them together, though, and the patient record is suddenly much harder to follow.

A secure handoff doesn’t settle what happens next

Case managers deal with this constantly. Their job often involves getting the right information to the right person before a delay turns into a bigger problem. The role of a case manager can involve coordinating providers, reviewing care plans, handling referrals, speaking with insurers, and helping patients move between settings. That work produces a lot of legitimate data sharing.

Picture a fairly ordinary discharge. A hospital sends a summary to a rehabilitation facility through an approved system. The facility downloads the document, adds it to its own chart, and forwards part of the information to a pharmacy. Meanwhile, a case manager uploads supporting records to an insurer for authorization.

The first transfer may have been handled exactly as intended. That still leaves a long list of practical questions. Where is the downloaded copy now? Does the rehabilitation facility back up that folder automatically? Who can open it? Does the insurer’s portal keep attachments after the authorization closes? Is someone maintaining another copy while waiting for a response?

Organizations that rely on external infrastructure to store or process ePHI also need to know how their HIPAA-compliant cloud services handle access, backups, recovery, and the systems underneath the application staff actually see. Those details matter long after somebody clicks “send.”

The HIPAA Security Rule is concerned with electronic protected health information that is created, received, maintained, or transmitted. “Maintained” is easy to overlook. A record doesn’t stop being sensitive because nobody is actively using it today.

Healthcare workers usually notice the visible handoff. They remember the fax, portal message, referral, or phone call. The less visible part is what happens afterward, when the information settles into somebody else’s workflow.

One patient record can become six working copies

Most healthcare organizations don’t have one neat version of a patient record moving from place to place.

They have an official record and a collection of working copies around it.

A nurse may export a medication list before calling another provider. A case manager might keep a spreadsheet showing which referrals are still pending. A utilization review team may attach clinical notes to an authorization request. A home health agency could download a PDF because the referring hospital and its own software don’t communicate cleanly.

There’s nothing unusual about that. In fact, some of these steps are what keep care moving.

But copies tend to outlive the reason they were created.

The spreadsheet that was meant to last three days is still on a shared drive four months later. A former employee still has access to a referral portal because that account wasn’t tied into the normal offboarding process. A desktop folder contains discharge paperwork that was supposed to be temporary. None of these situations requires a sophisticated attack. They exist because healthcare work is busy, systems don’t always cooperate, and temporary fixes have a habit of becoming permanent.

That’s where privacy controls can look stronger on paper than they do in practice.

An organization can lock down its EHR pretty well and still have patient information drifting through smaller systems that get far less scrutiny. AIHCP’s discussion of patient confidentiality challenges touches on access controls and secure communication, but those safeguards only help if you know everywhere the information is ending up.

A better way to spot problems is to look at what actually happens during a discharge. A file might be downloaded for review, uploaded again to a referral portal, mentioned in an email, and copied into a tracking sheet while staff wait for a response. If that referral drags on for several days, those extra copies can easily stick around longer than anyone intended.

You’ll often learn more from that conversation than from a polished diagram of the organization’s approved systems.

Vendors make the trail harder to see

Healthcare organizations depend on outside companies for all kinds of ordinary functions. Billing, scheduling, cloud storage, transcription, analytics, messaging, document management, and case management software may all involve outside vendors.

Staff rarely see the full stack behind those services.

Suppose a behavioral health practice uses an online case management system. The practice deals with one company and sees one login screen. Behind that screen, the application may rely on another provider for infrastructure, another for backups, and another for automated communications.

That doesn’t mean anything improper is happening. It does mean the data trail is longer than the user interface suggests.

HHS guidance on business associates addresses situations where outside organizations perform functions involving protected health information. Subcontractors can also become part of those relationships. For the healthcare organization using the service, the practical concern is understanding who can touch the data and under what arrangement.

“We use a HIPAA-compliant vendor” isn’t a very revealing answer.

A better review gets specific. What information is the vendor receiving? Is it keeping the data or merely passing it through? Can vendor employees access production systems? Who controls backups? What happens to stored information when the contract ends? Does the service depend on additional companies that also handle ePHI?

The answers don’t all need to come from nurses or case managers. Most won’t. But frontline staff can identify something the legal and IT teams can’t always see from contracts: how the service is actually being used.

That matters because the official use and the real use aren’t always identical.

A system purchased for referrals may become a place where staff also upload discharge records. A shared portal intended for one department may slowly become useful to three others. A vendor can end up handling more patient information than anyone anticipated when the agreement was signed.

NIST’s guidance for implementing the HIPAA Security Rule places heavy emphasis on understanding risk rather than simply collecting controls. That distinction is important. You can’t judge the risk around a vendor very well if nobody knows what information staff are actually putting into the system.

The workaround is often telling you something

Some of the most revealing privacy conversations start with a sentence nobody wants to hear:

“I know we’re not supposed to do it this way, but…”

Maybe the referral portal goes down regularly, so employees found another way to send paperwork. Maybe the case management system doesn’t show everything staff need on one screen, so someone created a separate spreadsheet. Maybe clinicians take screenshots because two systems make it painfully difficult to compare information.

It’s easy to treat those situations as training failures.

Sometimes they are. Sometimes they’re workflow failures.

If ten employees keep doing the same workaround, there’s probably a reason. Telling them for the eleventh time that the approved process is the approved process may not change much if the approved process prevents them from getting a patient discharged before the end of the day.

That doesn’t mean unsafe shortcuts should be accepted. It means they’re worth investigating rather than merely policing.

AIHCP has already looked at HIPAA compliance in a digital healthcare environment, including issues involving cloud storage, portals, mobile technology, and outside vendors. Care coordination is where many of those systems collide. A patient’s information can move through several of them during a single episode of care.

Wrap-up takeaway

Most people involved in a patient’s care are trying to do the same thing: get the information where it needs to go without slowing care down. The problem is that every extra download, portal, vendor, and temporary file leaves another place to keep track of. Over time, those small decisions can create a data trail that nobody fully owns anymore. That’s worth paying attention to because the weak spot may not be the main system everyone watches closely. It may be the forgotten account or working file sitting just outside it. 

Author Bio:

Ryan Harris is a writer covering technology, workplace learning, and operational risk. He writes about how training, digital systems, and everyday workflows affect safety, privacy, and decision-making, with a focus on making complex professional topics clear and practical.

 

Please also review AIHCP’s Managed Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Peptides and Exercise Recovery: What Current Research Can and Cannot Tell Us

Posted on by Joseph Gerard

Doctor, laptop and writing notes at night thinking about healthcare solution, idea or planning at hospital. Woman medical nurse working late in focus with notebook and computer for research at clinic.Written by Alex,

Recovery after strenuous resistance exercise or a soft-tissue injury is not a single event. It involves a sequence of overlapping biological processes. Mechanical loading can disrupt muscle proteins and connective tissue, alter local signaling, and trigger an inflammatory response. In the hours and days that follow, immune cells, fibroblasts, muscle cells, blood vessels, and components of the extracellular matrix participate in repair.

Muscle protein synthesis increases after resistance exercise, while injured tendons move through overlapping inflammatory, proliferative, and remodeling phases in which collagen is produced and reorganized. With repeated and appropriately dosed loading, these short-term responses contribute to longer-term tissue adaptation.

Peptides are frequently mentioned in discussions of this biology because the human body uses many peptide and protein signals to coordinate cellular activity. Hormones, growth factors, cytokines, and other signaling molecules can influence inflammation, vascular responses, protein turnover, and tissue remodeling. That observation is biologically relevant, but it does not establish that administering a separate peptide drug will accelerate recovery, heal an injury, or improve performance. Normal signaling inside the body and treatment with an externally administered compound are different scientific questions.

Why Peptides Are Not One Therapeutic Category

The word peptide describes a chemical structure a chain of amino acids not a uniform clinical effect. Different peptides act through different receptors and pathways, have different half-lives, and can produce very different effects depending on dose, tissue exposure, route of administration, and the health of the person receiving them.

Some peptide-based medicines have extensive clinical trial data and FDA-approved indications. Others remain investigational and have little reliable human evidence for the uses promoted online.

This distinction is especially relevant in exercise medicine. A plausible molecular mechanism is an early stage of research, not proof of a useful clinical outcome. A compound can alter angiogenesis, inflammatory mediators, fibroblast activity, or growth-factor signaling in a laboratory model without improving pain, physical function, return-to-activity time, reinjury risk, or long-term tissue integrity in people. Those outcomes require appropriately designed human studies.

BPC-157 Illustrates the Evidence Gap

BPC-157 is a 15-amino-acid peptide that has attracted attention for proposed effects on tendon, ligament, muscle, bone, and other tissues. Much of that interest originates from cell and animal experiments.

A 2025 systematic review of the orthopedic and sports-medicine literature identified 36 eligible studies, of which 35 were preclinical and only one was a clinical musculoskeletal study. That human report involved 12 patients receiving intra-articular treatment for chronic knee pain; seven reported relief lasting more than six months. The study was small and retrospective, however, and lacked the controlled design required to establish efficacy or characterize safety reliably.

A separate 2025 review reached a similar conclusion about the evidence gap. Although animal studies describe effects involving angiogenesis, fibroblast activity, inflammatory signaling, and tissue repair, the authors found only a very small number of human pilot studies across several unrelated clinical settings. Large, rigorous clinical trials capable of defining musculoskeletal benefits, adverse effects, appropriate dosing, and longer-term outcomes are lacking.

FDA materials provide another reason for caution when interpreting the available research. In 2026, the agency evaluated BPC-157 free base and BPC-157 acetate in connection with possible inclusion on the section 503A bulk drug substances list. FDA stated that neither form is a component of an FDA-approved drug and concluded that available clinical information was insufficient to characterize safety adequately.

Its review also discussed potential immunogenicity, peptide-related impurities, uncertainties surrounding active-ingredient characterization, and the lack of human data for several proposed routes of administration.

The FDA evaluation concerned a nominated use in ulcerative colitis rather than exercise recovery, so it should not be treated as a direct test of musculoskeletal effectiveness. It does demonstrate why questions about formulation, identity, human safety data, and regulatory status cannot be separated from clinical discussions of these compounds.

Why Animal Healing Data Cannot Be Assumed to Apply to Humans

Preclinical research is essential for identifying biological mechanisms and deciding which treatments deserve further investigation. Translation to clinical care, however, is not automatic.

An experimentally created tendon defect in a rodent is different from chronic human tendinopathy, a partial tear in a recreational athlete, or rehabilitation following surgical repair. Age, underlying health, injury severity, mechanical loading, and rehabilitation conditions can all alter recovery.

Dose is another major consideration. A quantity that produces a biological response in an animal cannot simply be converted into a human dose according to body weight. Absorption, metabolism, tissue distribution, clearance, and receptor activity can differ substantially between species. Route of administration also changes exposure: oral, subcutaneous, intravenous, intra-articular, nasal, and other routes cannot be assumed to produce equivalent effects or risks.

Study design adds further limitations. Animal experiments commonly use controlled injuries, relatively small samples, short observation periods, and laboratory endpoints such as histologic appearance, tensile strength, or expression of signaling molecules.

Clinical decision-making requires additional information. Patients and clinicians need to know whether treatment improves meaningful outcomes such as pain, mobility, function, return to activity, recurrence, and quality of life and whether adverse effects emerge after repeated or prolonged exposure. A favorable change in a microscopic marker does not by itself demonstrate better recovery for a patient.

When Patients Ask About Recovery Peptides

Patients increasingly arrive at appointments after encountering social-media discussions, clinic websites, commercial claims, and physician-authored or physician-reviewed resources such as peptide therapy guidance from Dr. Jonathan Snipes. A useful clinical response is to identify exactly what is being claimed and then place that information alongside the quality of the human evidence, available safety data, and the patient’s individual circumstances.

The first question is which compound the patient is actually considering. The specific chemical form, proposed dose, route of administration, and intended condition all matter. Clinicians can then ask whether evidence exists from controlled human studies for that particular indication or whether the rationale comes mainly from laboratory and animal experiments.

Regulatory status also deserves attention: an FDA-approved medication, an investigational substance, a compounded preparation, and a product purchased from an online supplier do not carry the same evidence or quality assurances.

Product quality is particularly relevant when the substance lacks an approved commercial drug formulation. Identity, purity, sterility, peptide-related impurities, storage conditions, and batch consistency can influence risk. FDA’s BPC-157 materials, for example, have noted concerns about characterization and inconsistent naming of related substances.

Medication history and medical conditions should also be reviewed rather than considering a recovery peptide in isolation. When human safety information is sparse, uncertainty extends to interactions, repeated exposure, immune reactions, and use in people with significant medical conditions. Injectable formulations raise additional questions about sterility and administration practices.

Just as important, the original musculoskeletal problem should be diagnosed. Persistent pain described as a tendon injury can arise from a partial tear, joint disease, referred pain, nerve involvement, stress injury, or another disorder requiring different management.

Beginning an experimental intervention without clarifying the diagnosis can complicate or delay appropriate imaging, rehabilitation, activity modification, or medical treatment.

Competitive athletes face an additional issue unrelated to whether a compound eventually proves medically useful. The 2026 World Anti-Doping Agency Prohibited List specifically names BPC-157 under S0, Non-Approved Substances, and prohibits it at all times, both in and out of competition. Athletes governed by anti-doping rules therefore need to consider eligibility and testing consequences independently of discussions about possible therapeutic effects.

Conclusion

Peptide science is biologically interesting because peptide and protein signals are part of the communication systems involved in inflammation, tissue repair, protein synthesis, vascular responses, and remodeling. Those physiological observations, however, do not establish the safety or effectiveness of administering a particular peptide as treatment.

Evidence must be evaluated compound by compound, for the specific indication and route being proposed. In the case of BPC-157, the preclinical musculoskeletal literature is substantially more developed than reliable human clinical evidence.

Exercise programming, adequate nutrition, accurate diagnosis of injuries, progressive rehabilitation, and appropriate medical care remain separate clinical considerations and should not be replaced by assumptions drawn from early peptide research.

 

Author BIO

Alex is a health and wellness writer covering rehabilitation, movement, exercise recovery, and evidence-informed approaches to physical well-being. His work focuses on translating complex health research into clear, accessible information that helps readers better understand recovery, mobility, and long-term physical health.

 

 

Please also review AIHCP’s Holistic Nursing Certification program and Nurse Courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Crisis Intervention/Trauma Informed Care: Disaster Mental Health

Posted on by Mark Moran

Disasters and traumatic events are part of human life.  1 in 5 individuals will face a traumatic event (Webber, et al., 2018).  Responses to traumatic events and disasters are a critical element of crisis intervention.  Crisis intervention helps stabilize a person by restoring equilibrium and mobility (James & Gilliland, 2013).  When one thinks of trauma and PTSD, the reality is most individuals who face disastrous events do not develop PTSD.  Human beings once stabilized are far more resilient than sometimes portrayed but without professional and on spot Disaster Mental Health support, as well as communal aid and support, then many individuals cannot foster that inner resiliency to recover. This short blog will look at Disaster Mental Health and the crucial role C Crisis Intervention plays in helping individuals return to a healthy mental baseline.

If you would like to learn more Crisis Intervention, as well as Trauma Informed Care, then please review AIHCP’s Crisis Intervention Counseling Certification, as well as AIHCP’s Trauma Informed Care Specialist Certification.

What Constitutes a Disaster?

Disasters can be natural, human made or human influenced. Please review AIHCP’s Crisis Intervention Program

A disaster according to The World Health Organization involves a complex humanitarian emergency in which a region, country or society experiences a total breakdown of authority resulting from external or internal conflict which requires an international response due to the inability of the locality’s capacity to face the problem (Webber, et al., 2018).   Disasters can be due to nature, human caused or with human influence.  Examples of natural disasters include hurricanes, tornadoes, floods, and earth quakes, while human caused disasters include war, terrorism, or even riots.  With human influence includes pollution, global warming, fire, gas leaks, displacements, or even hazardous waste (Webber, et al., 2018).  While this is a modest list to many possible scenarios, it encompasses what the U.N describes within a disaster as something that causes a massive disruption in the functioning of society that causes widespread human, material and environmental losses beyond the ability of the locality to manage with its resources (Webber, et al., 2018).

Disaster Response

Disaster response while not within the immediate topic of Disaster Mental Health represents the broader band in which Disaster Mental Health falls within.  Disaster response involves coordination between local, state, federal and sometimes international resources.  It involves working with religious, as well as non-profit organizations such as the Red Cross.  Within the United States, local government has limited resources.  The acting EMA Director, or director of the Emergency Management Agency reaches out to the state for assistance.  The state when overwhelmed then can reach out to FEMA or the Federal Emergency Management Agency which then coordinates the issue under the National Incident Management System (NIMS). (Webber, et al., 2018).  Various commanders are assigned within the NIMS with various officers who serve various capacities that meet the vast needs of the situation.  This ranges from needed resources, communication, coordination, physical and mental health care, shelter, food, medical, as well as helping others apply for necessary federal assistance.   Mental Health Professionals and Crisis Counselors are deployed under this leadership work within this framework.

From a mental health perspective, it is important to understand the phases of a disaster and its recovery and the corresponding emotional responses to each.  Pending on the phase of the disaster and its recovery has a huge impact on where the survivor is mentally and how well they are coping.  It is also can determine, if well after the disaster, if the person is suffering from any pathological reactions.

The first phase is the Impact Phase which follows the pre disaster.  Whether the impact is sudden or following multiple warnings and threats, an person will experience multiple emotional reactions to severe danger and loss.  In addition, their fight or flight responses will engage and different individuals will respond in different ways.  Within this phase shock, panic and overwhelmed feelings can be common as the mind faces traumatic conditions (Webber, et al., 2018).

The second phase is the Rescue Phase.  In this phase also referred to as the Heroic Phase, individuals may witness great acts of courage in helping one’s neighbor. The shift from fear and shock turns to altruism and helping.  Of course, some may be so shocked, inability to act may be perceived as cowardice and lead to later guilt and shame issues (Webber, et al., 2018).

The third phase involves the Remedy Phase or Honeymoon Phase.  Within this phase survivors feel a sense of euphoria and are overwhelmed by the generosity and help from others.  The public and communal support and prayers and good wishes towards a quick fix or repair become center stage to the survivor (Webber, et al., 2018).

The fourth phase is the Disillusionment Phase.  This period lasts from week 8 to year 1 and involves the realities of the loss, the lack of interest nationally, the bureaucratic halts, paperwork, lack of funding and triggering events from the initial disaster.  For many, this is the second disaster from a mental perspective (Webber. et al., 2018).

The final phase involves the Recovery Phase or Reconstruction Phase.  Following the anniversary, the locality rebuilds.  Some individuals rebuild, others move, but there is a return a new normal.  Memorials and healing also accompany the financial and physical rebuilding (Webber, et al. 2018).

Of course there are numerous variables to this.  Survivors differ in resiliency from a mental standpoint.  Others experience the disaster differently.  Others consist of more at risk communities due to age, capability, race, or income.  Others may face various other secondary issues in all aspects of life (Webber, et al., 2018).

 

What a Crisis Counselor Does and Does not Do

Crisis counselors help stabilize the survivor. Please also review AIHCP’s Crisis Intervention program

Crisis Counselors need to understand the paradigm shift of their purpose.  While some may be licensed counselors other may also be non-licensed professionals performing psychological first aid where needed.  Crisis Counselors are not on scene to offer diagnosis of clients.  The reality is most individuals who suffer a disaster will recover.  It is far to premature to diagnosis pathology when normal human reactions are responding to stress and loss.  Crisis counselors are meant to stabilize the situation for the person.  They are not there to diagnosis potential trauma or discuss the financial loss and procedures.  They can direct victims to resources but they are not there to advocate.  This takes time away from dealing with the primary goal of helping individuals stabilize mentally.  It is critical to also point, the purpose of crisis counseling is NOT TO DEBRIEF but to stabilize.  Studies have shown more emotional trauma occurs during the event when counselors attempt to debrief what occurred.  Finally, crisis counseling is anonymous for individuals needing it.  This is a key element of it.  It does not require records for mental health issues.

Unlike psychotherapy, crisis counseling is facing normal reactions to a horrible event.  There is no goal to fix or change the situation but to stabilize it.  Crisis counseling faces an adaptive response not a pathological response.   Instead of teaching one to learn new behaviors as in psychotherapy, crisis counseling looks to help the person find their original baseline.  Crisis counseling looks to promote self efficacy to the person.  It introduces brief psycho-education when needed and helps present the victim with necessary coping strategies to face the problem in the immediate event (Webber, et al., 2018).   In essence, the crisis counselor helps the person return to a mental baseline by restoring equilibrium and mobility to the person.   This is accomplished through offering protection, direction and connection for the victim (Webber, et. al., 2018).

Crisis Counselors are trained in Psychological First Aid.  This involves:

  1. Contact and Engagement
  2. Safety and Comfort
  3. Stabilization
  4. Information Gathering on current needs and concerns
  5. Practical Assistance
  6. Connection with social supports
  7. Information on coping
  8. Linkage with collaborative services

(Webber, et al., 2018).

To learn more about Psychological First Aid, please review AIHCP’s Blog on Psychological First Aid.

The Emotional State of a Disaster Victim

Triage of disaster survivors and outreach to the most vulnerable is key in disaster response and crisis intervention

A victim of a disaster can be suffering physically, emotionally, cognitively, or behaviorally (Webber, et al., 2018).  It is important to remember how the body responds to traumatic events.  Within the triune brain model, there are survival responses in the lower brain stem, emotional responses within the limbic system, and reasoning processes within the pre-frontal cortex.  Unfortunately, during the autonomous nervous system and its reaction to life threatening events, the survival mode kicks in and the reasoning center is overruled.  In this way, individuals respond via the sympathetic nervous system which incudes fight or flight response, and in parasympathetic responses a freeze, fawn or shutdown response.  Hyperarousal or hypoarousal are the two directions and it is hard to predict how a person will respond.  It is due to this that individuals will exhibit as wide variety of responses from a emotional, cognitive and behavioral fashion.  Some may be numb, while others quite anxious and irritable.   Some may be a danger to themselves or others.  Others may be out of control and angry.

To learn more about trauma responses, please review AIHCP’s video and blog on trauma responses.  Click here

Please also review AIHCP’s Trauma Informed Care Program.

When a disaster strikes and survivors and victims are brought to shelters, crisis counselors should compassionately linger watching for signs of individuals.  Studies show that 1/3 of individuals will not seek any help, while an additional 1/3rd need help but never seek it.  In essence, the crisis counselor initiates contact.  The crisis counselor outreaches to the survivor based on observations of physical, emotional, cognitive and behavioral signs of distress.  The crisis counselor also seeks out those who seem out of place, or disadvantaged such as children, or the elderly, or a person alone.   PsyStart trains crisis counselors with a color coordinated system for this psychological triage.  Within this triage, a purple coding is the highest level of concern which indicates the person is a harm to him/herself or others.  Red coding indicates intermediate intervention of high risk for crisis or long term mental health issues.  This includes extreme panic, witnessed death, awaiting death of a family member, death of a pet, significant injury, trapped or delayed rescue, home destroyed, family member missing or child separated from family.  A yellow coding should be utilized for those who are separated from family, unware of location, prior mental health issues, confirmed exposure to an agent, de-contaminated, received medical treatment, or has health concerns due to the incident.  Finally, a green coding exhibits no triage factors (Webber, et al., 2018).

In these situations, it is important to identify the most vulnerable and help them find the stability, emotional equilibrium,  and re-connection as possible to minimize trauma.

Please also review AIHCP’s Psychological Recovery blog to learn more.

Vicarious Trauma and Compassion Fatigue

It is important to note that healthcare workers and emergency rescue and mental health counselors can also experience trauma via the trauma of others as well as what they witnessed in a disaster site.  Vicarious trauma is the transfer of trauma from one to another.  It can effect the mental health of a counselor or rescue team member.  If symptoms manifest, it is critical to find mental help.  Many times, mental health professionals push themselves too far and ignore the signs of trauma.  It is important to recognize the nature of trauma not only in others but also oneself.  It is also important to recognize compassion fatigue and how it can affect oneself, one’s family and professional performance.

Conclusion

Please also review AIHCP’s Crisis Intervention Program as well as AIHCP’s Trauma Informed Care Program

Disasters occur and when a locality is overwhelmed, various levels of assistance are employed.  Disaster Mental Health is an important part of the response team.  Crisis Counselors assist survivors and victims with psychological first aid and help stabilize the individual.  Crisis counseling is far different than psychotherapy and is designed to help the person through moment of crisis and disaster to find stability.  It is important to understand the role of crisis counseling as well as applying essential triage to those emotionally affected by a disaster.  It is also equally important to monitor one’s own emotionally responses to a disaster.

Please also review AIHCP’s Crisis Intervention Program as well as AIHCP’s Trauma Informed Care Program.

Resource

James, R & Gilliland B. (2013). Crisis intervention strategies (Eighth Edition). Cengage

Webber, J. & Mascari, J.B. (Eds) (2018). Disaster mental health counseling : A guide to preparing and responding (Fourth Edition). American Counseling Association.

Additional AIHCP Blogs

Under standing Dissociation.  Click here

Additional Resources

The National Child Traumatic Stress Network.  Access here

Swaim, E (2022). “7 Reminders to Carry with You on Your Trauma Recovery Journey”.  Healthline.  Access here

“Resources on trauma and healing, including a guide inspired by ‘The Color Purple’”. APA.  Access here

“Recovering Emotionally After a Disaster”. American Red Cross.  Access here

Millions of Americans Struggle with Addiction So Here Is How Men Can Rebuild Their Lives in Recovery

Posted on by Joseph Gerard

Group psychotherapy for men with different problems and issuesWritten by Angela Rivera,

Getting through treatment is a major achievement. But if you’ve left a treatment program and are now thinking, “Okay, now what?”, you already understand the part that often gets far less attention: how to actually rebuild your life.

The need for actionable post-treatment support is enormous. According to the National Survey on Drug Use and Health, 44.6 million Americans had a substance use disorder in the previous year. That included 25.7 million people with alcohol use disorder and 26 million with a drug use disorder. About 7.1 million had both.

For men, it’s even harder. Men not only experience higher rates of several forms of substance use, but they are statistically more likely to end up in emergency departments or suffer fatal overdoses than women. Cultural expectations play a big role here, too. A man who has spent decades hearing that he should handle problems himself may find it especially difficult to admit that he needs help.

The good news is that recovery restores what addiction tends to take away: the ability to make deliberate choices about your time, health, relationships, work, and ultimately your future. You do not need to rebuild everything simultaneously, though. All you need is a practical place to start.

Treatment Ends But Recovery Keeps Going

The first weeks after treatment can be surprisingly uncomfortable. But understand one thing: this is normal and, in fact, to be expected.

Your schedule changes, you may sleep badly, and your appetite may be different. On top of that, you may have medical appointments, therapy, medication management, or lingering withdrawal-related symptoms to deal with. Then there are the less obvious problems: boredom, strained relationships, financial trouble, unemployment, and the sudden realization that a lot of your free time used to revolve around using.

None of these things mean that the treatment failed. They simply mean that treatment and long-term recovery solve different problems.

A person with opioid use disorder, for instance, may need ongoing medication treatment and monitoring after residential care. And someone recovering from alcohol use disorder may need continued counseling, medication, mutual-support groups, or some combination of these.

This is why your aftercare plan should come from your clinical team rather than a generic recovery checklist. Medication needs, mental health symptoms, sleep problems, and other medical concerns shouldn’t really be treated with a “wait and see” approach. They deserve professional attention.

Build a Day You Can Actually Repeat

How to make early recovery easier? Set a few daily goals you aim to hit every day.

For example, wake up at roughly the same time, eat regular meals, and take medications as prescribed. Go to work, school, treatment, or another productive activity. Exercise if you can, and attend your recovery support.

If this sounds too boring or simple, good. Boring routines have an advantage: they still work on a bad Tuesday.

Here’s another useful approach: create a “minimum day” for periods when motivation disappears. Meaning, decide in advance what you will do no matter how you feel.

That might mean getting out of bed, showering, eating breakfast, going to work, contacting your support person, and attending your scheduled meeting. This is flexible and personal, as some things may be more important to you than to others.

Get Specific About Stress

“Manage stress” may be reasonable advice, but it’s almost completely useless unless you define what stress looks like for you. So do that: what stresses you out the most?

Here are questions worth answering:

  • Do you become quick to anger?
  • Do you stop replying to texts and isolate yourself?
  • Do you start thinking about reaching out to old contacts?

Once you have your answer(s), map out your patterns using this sequence: Trigger → Warning Sign → Response

For example:

  • Argument with your partner → urge to leave and use → call your sponsor or therapist before leaving.
  • Paycheck arrives → thoughts about buying drugs → move money into essential expenses immediately.
  • Difficult day at work → isolation and irritability → eat, walk, shower, then contact someone.
  • Friday night → boredom and old drinking routines → make plans before Friday arrives.

The goal is to recognize your own early warning signs. That way, you have more room to respond before a craving becomes a crisis.

Your Living Environment Matters Greatly

What happens if you complete treatment and return to an “unsafe” environment? A place where people drink heavily, or drugs are readily available, or where everyone expects you to behave exactly as you did before. Yes, you are technically sober, but your environment is not helping you remain sober.

This is why recovery housing can make sense for many men. It’s a structured living environment that not only promotes sobriety but usually also independent growth, too, making it particularly valuable for early recovery.

If you’ve been Googling what is sober living, you probably have a good reason to consider it. There are many options, but Design for Recovery, for example, operates men’s sober living programs built around structure, peer accountability, and practical independence. Its programs include house meetings, recovery meetings, employment support, life-skills development, and a 12-Step foundation.

It’s not the same thing as detox or residential clinical treatment, though. A sober living home should not be treated as a substitute for medical or psychiatric care when those services are needed. The distinction is important when you are choosing a program because you want to know exactly what the residence provides and what it does not.

So if you’re seriously considering it, ask specific questions regarding:

  • House rules,
  • Drug and alcohol testing,
  • Meetings,
  • Medication policies,
  • Staff availability,
  • Relapse procedures,
  • Employment expectations,
  • How residents transition toward independent living.

Rebuild Your Independence in Pieces

After addiction, “get your life together” can sound like a ridiculous assignment (because it is). But here’s how you can make it work: break it down.

Work

If you already have a job, simply focus on keeping it while you stabilize your recovery. If you have been unemployed, update your résumé and apply for a manageable number of positions each week.

Keep in mind, employment is not only about income. A job can give your week structure, restore confidence, and reconnect you with a sense of responsibility.

Money

List your fixed expenses, debts, income, and immediate obligations. Pay essential bills first. But avoid trying to erase every financial mistake at once. A simple budget that you actually follow will always be better than an ambitious spreadsheet that lasts four days.

There are also recovery programs that provide financial coaching. Look for one that helps with the basics of budgeting, debt planning, credit education, and preparation for financial independence as part of its support.

Relationships

Do not demand instant forgiveness from people you hurt while using. You can apologize and make amends where appropriate. But trust usually comes from repeated behavior, not a particularly convincing conversation.

So, give people time to see that your actions have changed. You also have permission to create distance from relationships that still revolve around substance use, even if those relationships have existed for years.

Do Not Try to Replace Addiction With Isolation

Some men respond to recovery by going completely inward. They stop seeing old friends, which can be sensible. But then they stop seeing almost everyone, which creates another problem.

Peer support can provide something family members and clinicians cannot always provide: contact with people who understand the practical reality of staying sober. SAMHSA identifies peer support as a recovery resource for a reason: it can help people stay engaged, build skills, and connect with community.

You don’t need twenty new friends. Start with two or three people you can contact when things are going badly.

And make the relationship reciprocal. Listen to other people. Show up when you say you will. Help with ordinary things. Recovery communities become useful partly because people stop being isolated individuals and start becoming dependable members of a group.

Take Care of the Physical Basics

Sleep, nutrition, movement, and medical care are not side projects. They’re essentials.

Substance use often coexists with untreated medical conditions, poor nutrition, dental problems, poor sleep, and mental health concerns. That’s why medical attention is important: your primary care clinician and/or behavioral health providers can help determine what needs attention rather than leaving you to guess.

Exercise is especially important. It can help create structure and improve overall health, but you do not need to turn yourself into a fitness fanatic. A daily walk counts, and so does lifting weights a few times a week if that is something you enjoy.

A Practical First-90-Day Plan

If you need something more concrete, start here.

Weeks 1–2: Stabilize

Follow your discharge and medication plan. Keep appointments. Fix your sleep schedule as much as possible. Remove alcohol and drugs from your immediate environment. Tell at least one trusted person what support you need.

Weeks 3–6: Add responsibility

Return to work or school if you can. Establish a regular exercise routine. Attend recovery meetings or other support consistently. Start addressing debts, paperwork, transportation, and other neglected practical problems.

Weeks 7–12: Expand your life

Strengthen sober friendships. Take on more responsibility at work or home. Revisit longer-term education or career goals. Start planning what independent living will look like if you are in structured housing.

Importantly, know that the timeline is flexible. If your clinical team recommends a slower pace, follow that plan.

Recovery Has to Become a Life, Not Just an Absence

Addiction can consume an enormous amount of time and attention. Once that space opens up, you have to decide what goes there.

Work. Friends. Family. Exercise. Education. More money in your bank account. A clean apartment. A weekend you remember. Plans for next year. In short, ordinary but ultimately fulfilling things. Which is why they matter.

If you take anything from this piece, take this: you do not have to become a completely different person to recover; you just need to develop routines, relationships, and coping skills that make substance use less central to your life. For some men, that happens with outpatient care and a strong support network. For others, a structured sober living environment provides the extra accountability needed to make the transition.

Either way, the work continues after treatment. And that is not a bad thing. Treatment can help you stop the cycle, but recovery gives you the chance to decide what comes next.

References

  1. Substance Abuse and Mental Health Services Administration (SAMHSA). 2025 National Survey on Drug Use and Health (NSDUH).
  2. SAMHSA — 2025 National Survey on Drug Use and Health
  3. National Institute on Drug Abuse (NIDA). Sex and Gender Differences in Substance Use.
  4. NIDA — Sex and Gender Differences in Substance Use
  5. Design for Recovery. Sober Living Programs.
  6. Design for Recovery — Sober Living Programs
  7. Substance Abuse and Mental Health Services Administration (SAMHSA). Peer Support Workers for Those in Recovery.
  8. SAMHSA — Peer Support Workers

 Author Bio

Angela Rivera is a health writer who specializes in addiction care, telehealth, and behavioral science. With a background in patient education and evidence based communication, they focus on making complex clinical topics clear and approachable. Their work highlights practical strategies people can use to navigate recovery with confidence and support.

 

 

Please also review AIHCP’s Substance Abuse Practitioner Program and  CE courses to see if it meets your academic and professional goals.

5 Scenarios That May Point to an Occupational Health Concern  

Posted on by Joseph Gerard

Occupational Health written on the roadWritten by Deepika,

A patient’s symptoms often play tricks in a way that they act as footprints that don’t necessarily lead back to their origin. In other words, you may know that something has happened, but not where it all began. 

Occupation-related illnesses, although on the rise, are difficult to diagnose. A few reasons include: 

  • Similarities in clinical presentation 
  • Long latency periods between exposure and symptom onset 
  • Multifactorial etiology of chronic diseases 
  • Under-reporting of occupational conditions 

Despite the challenges, the scale of concerns makes it important to incorporate workplace cause-related health screenings. In 2024, 2.5 million non-fatal workplace injuries and illnesses were reported in the US private sector. Healthcare and social assistance recorded 3.4 cases per 100 full-time equivalent workers. 

How to tell if a patient’s workplace deserves a closer look? This article will discuss five distinct scenarios that point towards a workplace cause. 

 

Symptoms Improve During Time Away From Work 

In many cases, a patient’s symptoms have become such an ingrained part of their daily lives that they don’t see anything unusual. Even if the symptoms are recurring, they may not be able to connect them to their workplace. 

One important clue can be what happens when the patient is away from work. Say, coughing, wheezing, headaches, and skin irritation get better during weekends, vacations, or extended time away from work. The same return as soon as the patient resumes their work. 

The above-mentioned pattern calls for a closer look. NIOSH specifically recommends asking patients whether and how their symptoms change after a while away from work. A review of 2,050 physician charts at a large teaching hospital found that occupation was mentioned in only 28% of patient records. 

This is not surprising since it is easy to miss a relevant workplace clue during a clinical evaluation. Hence, the timing adds a worthwhile dimension to the patient’s history. As a healthcare professional, look for the following patterns: 

  • Symptoms getting worse during the work week and easing on weekends 
  • Feeling better during vacations or extended leave
  • Symptoms returning after resuming work 
  • Health issues worsening after a particular shift, task, or workday 
  • Palpable changes after moving to a different work area or performing different duties 

If there is a workplace exposure involved, it doesn’t always have to be obvious. NIOSH also recommends asking patients about new materials or activities introduced at work. Symptoms can fluctuate for many reasons, but a pattern gives it away. 

What to Do 

  • Compare the patient’s work days with their days off. 
  • Pinpoint the timing of the symptoms and their improvement. 
  • Ask directly about any workplace exposures. 

 

Multiple Coworkers Develop Similar Symptoms 

A workplace cause gets more difficult to ignore when multiple people develop similar symptoms. This is especially true if they belong to the same department, work area, or job role. 

The symptoms themselves do not have to be identical. Again, what matters here is the pattern. So, if several people working in the same environment begin experiencing similar issues around the same period, that’s a major sign. 

A 2025 CBS News report illustrated this pattern among Pasadena firefighters who battled the infamous Eaton fire. Captain Dave Marquez from the Pasadena Fire Department said, “For many of us, it was the worst exposure of our careers. Everybody shared similar symptoms.”

The crew had fought the fire for a brutally long 36 hours, and later submitted blood and urine samples to test for toxins. While every similar symptom may not point towards the same cause, a cluster does become good cause for questioning. Useful clues may include the following: 

  • Workers from the same area developing comparable problems 
  • Symptoms appearing after a shared workplace event or change 
  • Employees with similar duties experiencing similar complaints 
  • Unmistakable differences between affected and unaffected workers from different areas 

What to Do 

  • Ask the patient whether their coworkers share similar symptoms. 
  • Note the department, location, shift, or duties shared by the affected workers. 
  • Find out if the symptoms appeared after a specific event or change. 
  • Explore common exposure to dust, smoke, chemicals, equipment, etc. 
  • Record the patient’s account of the cluster and any workplace factors that make further evaluation necessary. 

 

Symptoms Start After a Workplace Change 

If a new symptom appears soon after the patient has shifted their workplace, then that may also serve as an important clue. Such a change may be obvious, such as introducing a new chemical or a piece of equipment. 

On the other hand, it may be a lot more subtle, such as moving to a different work area or changing shifts. The timing matters because it provides healthcare professionals with a specific point to investigate. Common workplace changes worth noting include: 

  • A new chemical, cleaning product, or material being introduced 
  • New machinery or equipment that produces dust, fumes, noise, or heat 
  • A change in work location, ventilation, or indoor conditions 
  • A change in schedule that alters sleep, meals, or recovery time 

Questions in this regard fall within the scope of occupational and environmental health. This branch of study examines how workplace and environmental conditions can influence health. So, those who pursue an occupational and environmental health degree focus beyond the symptoms to understanding exposures and assessing risks. 

Tulane University notes that the curriculum integrates public health principles with analytical methods in chemistry and statistics. Hence, the main focus areas are risk assessment, regulatory compliance, and exposure control. It makes sense since an understanding of the associated risk requires a more systematic assessment. 

What to Do 

  • Try finding out what exactly changed and when it occurred. 
  • Compare the timeline of the workplace change with the onset of symptoms. 
  • Ask what the patient was exposed to in the new environment. 
  • Determine whether symptoms vary with particular duties, location, or shifts. 
  • Document the suspected connection and see if further evaluation is necessary. 

 

A Known Workplace Hazard is Part of the Patient History 

Sometimes, the workplace connection is easier to recognize because the patient has a known exposure as part of their job. This may take the form of regular contact with chemicals, dust, fumes, biological materials, excessive heat, or radiation. 

In a 2025 field-based study, 58 construction workers in Central Florida were followed during a work shift. Then, their symptoms, hydration, and kidney function were assessed. Researchers found that 42% reported at least one heat-related illness symptom, 78% were dehydrated after the shift, and 38% showed evidence of acute kidney injury. 

It’s important to remember that a known workplace hazard is not always the cause behind a patient’s illness. However, when the patient regularly encounters a hazard that could affect their health, that exposure is a specific clinical clue worth investigating. Such a connection is especially important when: 

  • The patient regularly faces a known risk as part of their job. 
  • Symptoms appear mainly during and after the exposure. 
  • The patient has recently started working with a new substance, material, or process. 
  • The intensity or duration of exposure has increased, such as longer shifts or more time in a hot environment. 
  • Workplace protections have changed, including ventilation, hydration practices, etc. 

What to Do 

  • Ask exactly what the patient encounters at work, whether it be heat, chemicals, dust, noise, or another hazard. 
  • Find out how often or how long the conditions last. 
  • Consider whether the hazard affects the patient through breathing, skin contact, heat stress, or another route. 
  • Discuss ventilation, protective equipment, hydration, rest periods, and other controls relevant to the hazard. 
  • Think of further evaluation if the exposure and clinical presentation appear to be connected. 

 

The Condition is Unusual for the Patient’s Age or Circumstances 

It’s possible for a patient’s age, health history, or circumstances to not fit the condition that’s being evaluated. This is the case when a problem appears earlier than expected or has no clear, verifiable explanation. That’s when it’s time to look beyond the most common causes into the patient’s workplace environment. 

In a 2025 AP News report, this connection became a lot clearer. A Nevada dairy worker became infected with a newly identified strain of H5N1 bird flu after exposure at a cattle farm. The illness was mild, with redness in the eye and irritation as its main symptoms. 

However, the patient’s work with cattle provided an important part of their exposure history. The news report stated that at least 68 people in the US had been infected with bird flu the preceding year, with all but a small number having worked closely with cows or poultry. 

The example shows why an unusual condition or presentation may prompt a wider occupational history. As a healthcare professional, you may want to look more thoughtfully when: 

  • A condition appears unusually early for a patient’s age. 
  • The patient has few to no risk factors associated with the condition. 
  • The symptoms or diagnosis are unexpected given the patient’s health history. 
  • The patient’s occupation involves circumstances that may contribute to the condition. 

What to Do 

  • Determine which expected causes or risk factors are present or absent. 
  • Consider the patient’s occupation, daily activities, environment, and recent changes in circumstances. 
  • Ask whether symptoms began after starting a job, changing duties, or encountering a new workplace exposure. 
  • Avoid premature conclusions, treating the workplace as one possible factor. 

 

FAQs 

What are some signs that a health condition may be work-related? 

The most commonly observable signs include symptoms improving with time away from work, multiple coworkers being affected, and a known workplace hazard. If a condition appears to be quite unusual for a patient’s age or circumstances, that is another clue. 

What workplace factors should healthcare professionals ask patients about? 

It’s important to ask about chemicals, dust, fumes, heat, noise, biological materials, ventilation, and recent workplace changes. Also, consider asking whether the patient knows anybody from their workplace with similar issues. 

What should a healthcare professional do if a workplace cause is suspected? 

The first thing to do is to establish the timeline and compare symptoms across work and non-work periods. Then, document the relevant findings and consider appropriate health evaluation. A suspected connection should guide further assessment rather than being treated as proof of causation. 

 

Workplace Clues at a Glance 

What You Notice  What to Look For 
Symptoms improve away from work.  Better on weekends or leave 
Symptoms follow a workplace change.  New task, material, equipment, or location 
Coworkers have similar symptoms.  Shared duties, area, or exposure 
A known workplace hazard is present.  Heat, dust, fumes, chemicals, or noise 
The condition seems unusual.  Early onset or unexplained presentation 
Key questions to ask  Timing, tasks, exposures, and coworkers 
Clinical takeaway  Investigate patterns without assuming causation. 

As we discussed, the context surrounding the symptoms tells the whole patient story. So, when symptoms occur, whether coworkers are affected, and what conditions the patient encounters are all equally important. 

As per a 2026 study of 734 healthcare workers, workload, night shifts, and noise were all associated with occupational fatigue. Again, we see how several workplace factors can influence health at the same time. 

Next time a patient’s condition does not fully explain itself, look into their workplace conditions as well. A few thoughtful questions may reveal connections that are otherwise overlooked. 

Author Bio

Deepika has over six years of experience as a writer and editor. Passionate about words and learning, she takes an interest in a variety of niches. Her knack for turning complex ideas into relatable narratives allows her to resonate with the reader. When her pen falls silent, you can find her engrossed in a novel or getting her hands messy with fine arts. Through these, Deepika is committed to keeping her curiosity and creativity alive. 

 

References:

  1. Economics News Release. Employer-Reported Workplace Injuries and Illnesses (Annual) News Release. January 2026. US Bureau of Labor Statistics. 

https://www.bls.gov/news.release/osh.htm

  1. Saif Nadia, Socias-Morales Christina, et al. Primary Care and the Working Patient – Occupational Health Principles in Practice. October 2024. National Institute for Occupational Safety and Health. CDC. 

https://www.cdc.gov/niosh/bulletin/2024/primary-care-oh.html

  1. Tan Lanhui, Zhang Ruyi, et al. Multiple exposure sources and occupational fatigue profiles among healthcare workers: a cross-sectional latent profile analysis. 2026. Frontiers. 

https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2026.1811642/full

  1. Chicas C Roxana, et al. Acute Kidney Injury Among Florida Construction Workers: A Pilot Study. March 2025. PubMed. 

https://pubmed.ncbi.nlm.nih.gov/39706579/

 

Please also review AIHCP’s Health Care Certification program and CE courses see if it meets your academic and professional goals.  These programs are online and independent study and open to qualified professionals seeking a four year certification

Therapeutic Efficacy of Serrapeptase: Evaluating Systemic Enzyme Therapy in Modern Clinical Practice

Posted on by Joseph Gerard

Computer laptop with medical sign icon concept of telemedicine a

Written by Dr. Sarah Jenkins,

Routine clinical care of acute and chronic inflammatory diseases continues to be an integral part of everyday care. NSAIDs and corticosteroids are the traditional mainstay of pharmacological therapy and the indefinite use of these often produces an unfavorable gastrointestinal, renal and cardiovascular side effect. Thus, there is a growing demand in the medical community for discovery and validation of alternative or adjunctive anti-inflammatory modalities which may have good efficacy and better safety margins. Of the most promising of these substitutes is systemic enzyme therapy, a treatment which has been increasingly supported by empirical evidence over the past few decades.

Specific biological catalysts, or enzymes that stem from systemic enzyme therapy work on the immune system by controlling its response and promoting tissue repair, are at the center of the treatment. The clinical use of Proteolytic enzymes has proven to be quite promising in reducing edema, controlling inflammation and hastening the recovery process in both postoperative and traumatic clinical situations (Nair et al., 2022). A specific group of biocatalysts is the serrapeptase, also known as serratiopeptidase, a highly studied compound that is clinically useful.

 

The Biochemical Profile and Mechanism of Action

Serrapeptase is a very active protease enzyme which was extracted from an enterobacterium named Serratia marcescens E-15 which is absent from the pathogenic group of Serratia, but present in the intestine of Bombyx mori, commonly known as the silkworm. The enzyme’s strong fibrinolytic and proteolytic activity are utilized in nature by the silkworm in order to break down the tough protective cocoon of the silkworm.

In human physiology, serrapeptase acts by several different, but complementary, biochemical pathways. In fact, it has a strong anti-edemic effect which reduces the swelling of tissues. Serrapeptase helps remove abnormal exudates and denatured proteins, that often build up in localized areas of tissue damage. Serrapeptase can effectively inhibit the inflammatory cascade’s key chemical mediators of inflammation such as bradykinin, histamine and serotonin, which in turn has a beneficial effect on vascular permeability and the localized edema that can occur as a result of the inflammatory process.

Secondly, serrapeptase has a very high fibrinolytic activity. Actively breaks down dead/failing tissues like fibrin but does no damage to thriving/living cells. This selective proteolysis helps to remove obstruction from microcirculation at the injury site and allows better oxygen and nutrient transfer to the site which is crucial for tissue repair, enhancing the removal of metabolic waste. In addition, serrapeptase partly prevents the release of amine substances in inflammatory tissues which makes it an excellent analgesic while not having the cyclooxygenase, or COX, pathway typical of most NSAID’s.

Clinical Applications in Healthcare

Its multi-facet pharmacological properties paved the way for clinical studies and eventual application in a variety of therapeutic areas.Its pleiotropic properties are the reason why it has been the subject of clinical investigation and then applied to a variety of therapeutic fields. Its physiological functions can be adapted and utilized by healthcare practitioners in their practice for optimal patient outcomes.

Otolaryngology and ENT

Chronic inflammation can cause excessive production of thick, viscous mucus leading to excessive chronic sinusitis, rhinitis and bronchitis in the field of otorhinolaryngology. Serrapeptase has been shown to be effective in changing the viscoelasticity of sputum and nasal secretors in clinical evaluations. Mucin is a macromolecule that its viscosity is reduced by the enzyme which allows the expectoration of larger amounts for mucociliary clearance (Mazzone et al., 1990). Thus it is an important adjunctive treatment for respiratory diseases that involve heavy secretion of mucus.

Oral and Maxillofacial Surgery

Edema and pain after surgery are a big problem in maxillofacial surgery, especially after surgical removal of impacted mandibular third molars. These cases have been subjected to a double-blind and placebo controlled clinical test of the prophylactic use of serrapeptase. The results are usually statistically significant and show a decrease in post-operative trismus, which is the stiffness of the jaw, swelling of the face and pain intensity when compared with placebo suggesting an effective alternative to corticosteroids for the management of surgical trauma (Al-Khateeb & Nusair, 2008).

Orthopedics and Traumatology

The rapid, successful healing of acute inflammation has been essential in musculoskeletal injuries in order to avoid chronic inflammation and functional losses. Serrapeptase is commonly used in sports medicine and orthopedics to treat sports injuries like sprains, torn ligaments and post-operative orthopedic recovery. This increases the speed of reabsorption of hematomas and reduces tissue swelling as a result of this, patients can return to normal functional status (Tiwari, 2017) to a more functional level of mobility earlier on.

The Role of Serrapeptase in Biofilm Disruption

The subject of serrapeptase in relation to infectious diseases and resistance to them is one of the most interesting and current research fields related to serrapeptase. A lot of pathogenic bacteria cope with host immune system and pharmacological treatment by forming these complex polysaccharide matrices called extracellular polymeric substances or EPS that encapsulate the bacterial communities.

Recent microbiological investigations have found serrapeptase to be a strong inhibitor of the effects of biofilms. Enzymatically breaking down the structure of the biofilm matrix, Serrapeptase removes the bacteria’s protection. The action is very important in concentrating the antibiotic effect locally and helping the action of the antibiotics in use at the time (Selan et al., 1993). The addition of targeted proteolytic enzymes is an exciting new avenue in antimicrobial stewardship for the healthcare provider treating chronic infections with organisms that routinely form biofilms. This is particularly relevant for pathogens in the respiratory tract or prosthetic implant-associated infections, such as recurrent joint infections.

Pharmacokinetics and Formulation Imperatives

Pharmacokinetics of serrapeptase need to be carefully controlled in order that the efficacy of the product can be realized. Unlike most enzymes, the enzyme serrapeptase is protein based and is spontaneously decomposed by highly acidic environment of the stomach, specifically gastric acid and pepsin. In the stomach the enzyme is denatured, so its systemic absorption in the small intestine is entirely cancelled out making the therapy without any effect.

Systemic enzyme treatment is then recommended and when so, it is medically obligatory to indicate enzyme preparations with high level enteric coating. Since the enzyme would not be affected by stomach acid, the capsules are enteric coated, releasing the enzyme along the way in the alkaline environment of the small intestine where it is then absorbed into the systemic venous circulation via the intestinal lymphatic system. The provider should recommend the use of formulations which are tested rigorously, for instance, Liver Medic’s serrapeptase supplements optimised to avoid breakdown by gastric enzymes, to maximise systemic bioavailability and/or to provide a constant therapeutic effect throughout treatment for maximum efficacy in clinical outcomes.

Safety Profile and Contraindications

On the whole, systemic enzymes are safe and well tolerated, but require proper clinical judgement on the part of the healthcare provider when deciding on the use of systemically acting enzymes. Some gastrointestinal upset, such as nausea or loss of appetite, is the most common side effect; this is usually mild and does not last long.

As it has fibrinolytic activity, use Serrapeptase with caution in patients with bleeding disorders or those on aggressive antiplatelet and/or anticoagulant medications that could potentially interact with Serrapeptase and increase the risk of bleeding, such as Warfarin, Clopidogrel. Two weeks before being scheduled for any surgeries, systemic enzyme therapy is routinely stopped, and sometimes reasoned.

Conclusion

By combining synthetic systemically acting enzymes, a multi-targeted treatment approach that suits today’s integrative clinical practice in the treatment of inflammation. The versatility of Serrapeptase is particularly impressive for its ability to treat all these conditions: edema, pain, mucous coat issues, and even bacterial biofilm, without experiencing the gastrointestinal or renal side effects as with extended use of NSAID’s. With ongoing research and investigation of these biocatalysts’ vast biochemical potential, serrapeptase will most likely become an added significant treatment tool in the modern day’s ‘medical arsenal’.

References

Al-Khateeb, T. H., & Nusair, Y. (2008). The anti-inflammatory effect of a proteolytic enzyme (serrapeptase) on trismus, pain and swelling following third molar extraction of the mandible. International Journal of Oral and Maxillofacial Surgery, 37(3), 264-268. https://doi.org/10.1016/j.ijom.2007.11.011

Nair, S. R., & Sandeep, R. (2022). A systemic enzyme with pleiotropic therapeutic properties that is called Serrapeptase. Pharmacological Reports, 74, 1-14.

Tiwari, M. (2017). Serratiopeptidase – a role in the resolution of inflammation. Wang FY, Yang CP, Huang L et al (2017) Evaluation of the Stability of Roscovitina in Pharmaceutical Suspensions. Asian Journal of Pharmaceutical & Clinical Research 10(5): 221-224.

Author Bio:

Sarah Jenkins Ph.D. is an independent Clinical Researcher, Medical Writer with special interests in Integrative Pharmacology and Advanced Anti-inflammatory Therapies. She has written and peer-reviewed papers and courses on the positive evidence and support from very holistic modalities offering helpful optimization strategies on managing chronic disease and Post Surgery improvements and regimens in healthcare professionals.